303 related articles for article (PubMed ID: 29294343)
1. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Singh S; Houng AK; Reed GL
Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
[TBL] [Abstract][Full Text] [Related]
2. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
Houng AK; Wang D; Reed GL
Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
[TBL] [Abstract][Full Text] [Related]
3. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
4. N-myc downstream-regulated gene 2 protects blood-brain barrier integrity following cerebral ischemia.
Takarada-Iemata M; Yoshikawa A; Ta HM; Okitani N; Nishiuchi T; Aida Y; Kamide T; Hattori T; Ishii H; Tamatani T; Le TM; Roboon J; Kitao Y; Matsuyama T; Nakada M; Hori O
Glia; 2018 Jul; 66(7):1432-1446. PubMed ID: 29476556
[TBL] [Abstract][Full Text] [Related]
5. Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin.
Reed GL; Houng AK; Wang D
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2586-93. PubMed ID: 25256235
[TBL] [Abstract][Full Text] [Related]
6. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.
Rosell A; Cuadrado E; Ortega-Aznar A; Hernández-Guillamon M; Lo EH; Montaner J
Stroke; 2008 Apr; 39(4):1121-6. PubMed ID: 18323498
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
8. Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription.
Sarami Foroshani M; Sobhani ZS; Mohammadi MT; Aryafar M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3053-3065. PubMed ID: 30093209
[TBL] [Abstract][Full Text] [Related]
9. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
Frankowski JC; DeMars KM; Ahmad AS; Hawkins KE; Yang C; Leclerc JL; Doré S; Candelario-Jalil E
Sci Rep; 2015 Dec; 5():17956. PubMed ID: 26648273
[TBL] [Abstract][Full Text] [Related]
10. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
11. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
Jin R; Xiao AY; Chen R; Granger DN; Li G
Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
[TBL] [Abstract][Full Text] [Related]
13. Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice.
Seo HB; Kang BK; Kim JH; Choi YW; Hong JW; Choi BT; Shin HK
BMC Complement Altern Med; 2015 May; 15():157. PubMed ID: 26012470
[TBL] [Abstract][Full Text] [Related]
14. Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
Singh S; Houng AK; Wang D; Reed GL
J Thromb Haemost; 2016 Sep; 14(9):1822-32. PubMed ID: 27319402
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Saleem S; Wang D; Zhao T; Sullivan RD; Reed GL
Neuroscience; 2021 Apr; 460():120-129. PubMed ID: 33465414
[TBL] [Abstract][Full Text] [Related]
16. Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
Jha R; Battey TW; Pham L; Lorenzano S; Furie KL; Sheth KN; Kimberly WT
Stroke; 2014 Apr; 45(4):1040-5. PubMed ID: 24619394
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
18. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke.
Khatri R; McKinney AM; Swenson B; Janardhan V
Neurology; 2012 Sep; 79(13 Suppl 1):S52-7. PubMed ID: 23008413
[No Abstract] [Full Text] [Related]
20. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.
Gidday JM; Gasche YG; Copin JC; Shah AR; Perez RS; Shapiro SD; Chan PH; Park TS
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H558-68. PubMed ID: 15764676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
